We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Is Lloyds Banking Group PLC Set To Benefit From TSB Banking Group PLC’s Takeover?

Lloyds Banking Group PLC (LON: LLOY) is not set to benefit from the takeover of TSB Banking Group PLC (LON: TSB).

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

TSB (LSE: TSB) announced today that it has reached an agreement on the terms of a recommended cash offer for itself by Spanish lender, Banco de Sabadell. Under the terms of the offer, TSB shareholders will receive 340p per share in cash, valuing the bank at approximately £1.7bn. 

TSB’s largest shareholder, Lloyds (LSE: LLOY), also stated its commitment to the deal. Lloyds has agreed to sell a 9.99% interest in TSB to Sabadell, and the group has entered into an irrevocable undertaking to accept the offer in respect of its entire remaining 40.01% shareholding in TSB. 

Should you buy Lloyds Banking Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

A clean break

This deal will allow Lloyds to make a clean break from TSB, although it seems as if the bank will lose out financially.  

Lloyds is set to receive £170m for its 9.99% stake in TSB on 24 March, followed by a further transaction of £680m for Lloyds’ remaining TSB stake. The total cash consideration Lloyds could receive from the deal is £850m, which will be used by the bank for general corporate purposes.  

Unfortunately, according to today’s press release on the matter, the transaction will lead to a separation charge on Lloyds’ income statement of approximately £640m. Additionally, on the completion of the deal, Lloyds’ equity tier 1 capital ratio — capital cushion — will fall by an estimated 0.27% as costs of the deal outweigh the benefits. 

Nevertheless, for TSB shareholders the deal is great news.  Indeed, TSB’s shareholders will receive 340p in cash for their shareholding, while still qualifying for the bonus share scheme implemented by Lloyds when it floated TSB in June last year. The 12 month lock up period for the bonus scheme ends on 25 June, when Lloyds will make arrangements to pay, any investors who would have been entitled to receive bonus shares under the terms of the scheme, the cash value of those bonus shares at the offer price to be paid by Sabadell. 

So, as well as the transaction costs, it looks as if Lloyds will lose money from the bonus share scheme as well. The cash payments appear to be coming from the bank’s own back pocket. 

But there’s still a chance that the TSB-Sabadell deal will be blocked by regulators. Until the transaction is approved, it’s not time to celebrate. 

The bottom line

All in all, it looks like Lloyds won’t see any benefits from the TSB-Sabadell deal. However, the deal will allow the bank to make a ‘clean break’ from its smaller spin-off, which is a suitable compromise.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female analyst working at her desk in the office
Investing Articles

Lloyds shares seem unstoppable — but what do investors need to watch out for?

Lloyds' shares seem to be on an unstoppable march back to their former glory. But what do investors need to…

Read more »

Landlady greets regular at real ale pub
Investing Articles

By 2028, the dividends from Diageo shares could recover to…

Diageo shares saw their dividend slashed as a new turnaround strategy took shape. But could the payout already be on…

Read more »

Percy Pig Ocado van outside distribution centre
Investing Articles

By July 2027, the Ocado share price could go from 187p to…

With Ocado bagging new tech deals with the likes of Asda, is its bombed-out share price screaming opportunity to me…

Read more »

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

By 2030, the dividends from Legal & General shares could grow to…

With the highest yield in the FTSE 100 and a clear multi-year growth plan, could Legal & General shares be…

Read more »

Aviva logo on glass meeting room door
Investing Articles

9% yield? Here’s the dividend forecast for Aviva shares to 2030

Aviva shares already yield 5.8%. But according to long-term dividend forecasts, that could climb to nearly 9% within four years!…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Forget Rolls-Royce shares, this incredible penny stock is forecast to soar 762%!

Faron Pharmaceuticals shares are forecast to gain 762% in the coming 12 months, mimicking the recent performance of Rolls-Royce shares.

Read more »

Close-up of children holding a planet at the beach
Investing Articles

How to turn a £20,000 ISA into a £20-a-day passive income stream

Does earning regular passive income seem out of your grasp? Break it down to a simple, step-by-step plan, and it’s…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

3 UK shares tipped to soar 100% (or more) in the next 12 months

Mark Hartley assesses the growth potential of three lesser-known UK shares with optimistic broker targets. Could they double in value…

Read more »